Algeria vs France: Previously treated cases tested for RR-/MDR-TB
Algeria
8.2%
in 2023
France
4.2%
in 2024
Algeria rank
168th
France rank
170th
Previously treated cases tested for RR-/MDR-TB over time
- Algeria
- France
How they compare
Algeria currently reports 8.2% against 4.2% in France, a difference of 4.0%.
That makes Algeria's figure about 2.0 times France's.
The two have swapped places 3 times across 10 shared years of data; in 2005 it was France ahead.
Algeria ranks 168th and France ranks 170th of 180 countries.
Across the 3 decades both report, Algeria averaged higher in 1 and France in 2.
Head to head by decade
| Decade | Algeria | France | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 23.0% | 30.0% | 7.0% | France |
| 2010s | 38.4% | 85.2% | 46.7% | France |
| 2020s | 20.7% | 10.0% | 10.8% | Algeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Algeria or France?
- Algeria, at 8.2% against 4.2% in France as of 2023.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Algeria and France?
- 4.0%, with Algeria ahead.
- How many years of comparable data are there for Algeria and France?
- 10 years are reported by both, from 2005 to 2023.
- How do Algeria and France rank globally for previously treated cases tested for rr-/mdr-tb?
- Algeria ranks 168th and France ranks 170th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.